Guided Therapeutics Inc (GTHP) stock
GTHPOTCElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
$0.16−0.03 (-15.79%)
Close on Oct 19, 2026Market cap $15.45MP/E –Yield –
Guided Therapeutics profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Guided Therapeutics's profit margin for the twelve months ending Jun 30, 2026 was -471.5%. For fiscal 2025 it was -416.7%, against -34528.6% the year before. The highest annual figure on record is 1782.5% in fiscal 2018.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -416.7% | +34111.9 |
| FY2024 | Dec 31, 2024 | -34528.6% | −30968.4 |
| FY2023 | Dec 31, 2023 | -3560.2% | +29832.1 |
| FY2022 | Dec 31, 2022 | -33392.3% | −30836.8 |
| FY2021 | Dec 31, 2021 | -2555.6% | −2282.0 |
| FY2020 | Dec 31, 2020 | -273.5% | +5062.6 |
| FY2019 | Dec 31, 2019 | -5336.1% | −7118.6 |
| FY2018 | Dec 31, 2018 | 1782.5% | +6166.1 |
| FY2017 | Dec 31, 2017 | -4383.6% | +12049.7 |
| FY2015 | Dec 31, 2015 | -16433.3% | −1228.7 |
| FY2014 | Dec 31, 2014 | -15204.6% | −14324.7 |
| FY2013 | Dec 31, 2013 | -879.9% | −749.5 |
| FY2012 | Dec 31, 2012 | -130.4% | +54.3 |
| FY2011 | Dec 31, 2011 | -184.7% | −100.1 |
| FY2010 | Dec 31, 2010 | -84.6% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q4 FY2025 | Dec 31, 2025 | -206.4% | −199.7 |
| Q3 FY2025 | Sep 30, 2025 | -1236.7% | −30.4 |
| Q2 FY2025 | Jun 30, 2025 | -693.2% | +2845.5 |
| Q4 FY2024 | Dec 31, 2024 | -65200.0% | −61250.0 |
| Q1 FY2024 | Mar 31, 2024 | -6.7% | +36726.6 |
| Q4 FY2023 | Dec 31, 2023 | -1206.3% | +17313.8 |
| Q2 FY2023 | Jun 30, 2023 | -3538.6% | +6601.4 |
| Q1 FY2023 | Mar 31, 2023 | -3950.0% | −3210.0 |
| Q3 FY2022 | Sep 30, 2022 | -36733.3% | −37091.2 |
| Q2 FY2022 | Jun 30, 2022 | -18520.0% | +33180.0 |
| Q1 FY2022 | Mar 31, 2022 | -10140.0% | −18804.0 |
| Q4 FY2021 | Dec 31, 2021 | -740.0% | −2785.5 |
| Q3 FY2021 | Sep 30, 2021 | 357.9% | −6410.9 |
| Q2 FY2021 | Jun 30, 2021 | -51700.0% | −39100.0 |
| Q4 FY2020 | Dec 31, 2020 | 8664.0% | +274964.0 |
| Q3 FY2020 | Sep 30, 2020 | 2045.5% | +3239.9 |
| Q4 FY2019 | Dec 31, 2019 | 6768.8% | +13297.3 |
| Q3 FY2019 | Sep 30, 2019 | -12600.0% | +24700.0 |
| Q2 FY2019 | Jun 30, 2019 | -266300.0% | −309050.0 |
| Q1 FY2019 | Mar 31, 2019 | -1194.4% | −28244.4 |
| Q4 FY2018 | Dec 31, 2018 | -6528.6% | +1635.9 |
| Q3 FY2018 | Sep 30, 2018 | -37300.0% | −30133.3 |
| Q2 FY2018 | Jun 30, 2018 | 42750.0% | +43981.0 |
| Q1 FY2018 | Mar 31, 2018 | 27050.0% | +27559.5 |
| Q4 FY2017 | Dec 31, 2017 | -8164.5% | −7942.4 |
| Q3 FY2017 | Sep 30, 2017 | -7166.7% | – |
| Q2 FY2017 | Jun 30, 2017 | -1231.0% | – |
| Q1 FY2017 | Mar 31, 2017 | -509.5% | – |
| Q3 FY2016 | Sep 30, 2016 | -222.1% | – |
See a number that looks wrong?